Pfizer INC Form 4 insider transactions

Pfizer CEO Albert Bourla acquired 25 phantom stock units as part of a deferred compensation plan, increasing his beneficial ownership to 730,907 units.

Pfizer's Chairman and CEO, Albert Bourla, acquired 24 phantom stock units as part of a deferred compensation plan on August 29, 2025.

Pfizer's Chairman and CEO, Albert Bourla, acquired 24 phantom stock units under a deferred compensation plan.

Pfizer's Chairman and CEO, Albert Bourla, acquired 26 phantom stock units through a deferred compensation plan.

Pfizer's Chairman and CEO, Albert Bourla, acquired additional phantom stock units through the company's deferred compensation plan, increasing his indirect beneficial ownership.

Pfizer Inc. Director Cyrus Taraporevala acquired 1,547.03 phantom stock units as deferred compensation, increasing his total beneficial ownership to 21,601.073 units.

Pfizer Director James C. Smith has acquired 1,856.436 phantom stock units as part of deferred director's compensation, increasing his beneficial ownership to 157,093.034 units.

Pfizer Director James Quincey has acquired 1,598.597 phantom stock units, increasing his beneficial ownership to 69,204.871 units, as part of deferred director's compensation.

Pfizer Inc. Director Shantanu Narayen reported the acquisition of 2,062.706 phantom stock units as deferred compensation, valued at $24.24 per unit, bringing his total beneficial ownership of derivative securities to 173,181.749 units.

Pfizer Inc. Director Joseph Echevarria acquired 1,908.003 phantom stock units as deferred compensation, increasing his beneficial ownership to 140,751.406 units.

Pfizer's Chairman and CEO, Albert Bourla, acquired 25 phantom stock units on June 30, 2025, increasing his total beneficial ownership to 718,220 units.

Pfizer Inc. Chairman and CEO Albert Bourla has acquired 24 additional phantom stock units, valued at $24.54 each, as part of a deferred compensation plan.

Pfizer's Chairman and CEO, Albert Bourla, has reported the acquisition of 26 phantom stock units as part of the company's Nonfunded Deferred Compensation and Supplemental Savings Plan.

Pfizer's CEO, Albert Bourla, reports acquiring 27 phantom stock units under the company's deferred compensation plan.

Pfizer's Chairman and CEO, Albert Bourla, reported the acquisition of 25 phantom stock units on April 30, 2025, according to a Form 4 filing with the SEC.

Director Suzanne Nora Johnson acquired 8,999 phantom stock units of Pfizer Inc. as part of deferred compensation.

Director Ronald E. Blaylock reports acquisition of 8,999 phantom stock units of Pfizer Inc. on April 24, 2025, as part of deferred compensation.

Director Mortimer J. Buckley acquired 8,999 phantom stock units of Pfizer Inc. as part of a deferred compensation plan.

Director Susan Desmond-Hellmann acquired 8,999 phantom stock units of Pfizer as part of a deferred compensation plan.

Director Joseph Echevarria acquired 8,999 phantom stock units of Pfizer Inc. as part of a deferred compensation plan.

Director Scott Gottlieb acquired 8,999 phantom stock units in Pfizer, Inc. as part of a deferred compensation plan.

Director Susan Hockfield acquired 8,999 phantom stock units of Pfizer Inc. as part of deferred compensation.

Director Dan R. Littman reports acquisition of phantom stock units in Pfizer Inc. through a nonfunded deferred compensation plan.

Director Shantanu Narayen acquired 8,999 phantom stock units of Pfizer as part of a deferred compensation plan.

Director James Quincey acquired 8,999 phantom stock units of Pfizer as part of a deferred compensation plan.

Director James C. Smith reports acquisition of phantom stock units in Pfizer Inc. through a nonfunded deferred compensation plan.

Director Cyrus Taraporevala reports acquisition of 8,999 phantom stock units of Pfizer Inc. on April 24, 2025, as part of deferred compensation.

Pfizer's Chairman and CEO, Albert Bourla, reported the acquisition of 45 phantom stock units in a recent SEC filing.

Pfizer's Chairman and CEO, Albert Bourla, reports the acquisition of 1,484 phantom stock units through the company's deferred compensation plan.

Director Cyrus Taraporevala reported the acquisition of phantom stock units representing deferred director's compensation.